Medicines

How Your Phone's SIM Card Could Make Medicines Cheaper |  Digital trends

How Your Phone’s SIM Card Could Make Medicines Cheaper | Digital trends

Electronic gadgets are a potpourri of expensive and rare items, but the majority of them end up accumulating in an electronic waste landfill instead of being recycled. It’s not because we don’t have the technology to recycle it, but because of factors like cost management and process efficiency. SIM cards are among the parts of …

How Your Phone’s SIM Card Could Make Medicines Cheaper | Digital trends Read More »

Pharmacies in Yuba City are running out of medicines amid rising respiratory illnesses nationwide

Pharmacies in Yuba City are running out of medicines amid rising respiratory illnesses nationwide

Over-the-counter medications are in increasing demand as people contract respiratory viruses at higher rates. As of Nov. 30, the Department of Health and Human Services recorded 19,593 new flu hospitalizations — up from 11,378 last week — in the United States and 3,661 here in California. This increased number of illnesses prompts people to seek …

Pharmacies in Yuba City are running out of medicines amid rising respiratory illnesses nationwide Read More »

Ionis Announces European Medicines Agency Accepts Marketing Authorization Application for Tofersen to Treat Rare Genetic Form of ALS

Ionis Announces European Medicines Agency Accepts Marketing Authorization Application for Tofersen to Treat Rare Genetic Form of ALS

SOD1-ALS affects approximately 2% of people living with ALS worldwide1 If approved, tofersen would be the world’s first treatment to target a genetic cause of ALS EMA acceptance follows FDA acceptance of tofersen NDA earlier this year CARLSBAD, Calif., December 5, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the European Medicines …

Ionis Announces European Medicines Agency Accepts Marketing Authorization Application for Tofersen to Treat Rare Genetic Form of ALS Read More »

Novartis and Medicines For Malaria Venture make significant progress on malaria treatment front

Novartis and Medicines For Malaria Venture make significant progress on malaria treatment front

FILE – This file photo provided by the Centers for Disease Control and Prevention (CDC) shows a … [+] feeding female Anopheles stephensi mosquito crouched forward and down on her forelegs on a surface of human skin, getting her blood meal through her sharp needle-like labrum, which she had inserted into its human host. (James …

Novartis and Medicines For Malaria Venture make significant progress on malaria treatment front Read More »

Almirall joins FACILITATE, a patient-focused Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants

Almirall joins FACILITATE, a patient-focused Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants

Almirall brings experience in privacy and pharmaceutical law, as well as in developing guidance, standards and recommendations for communicating clinical trial data to patients The project will last four years and will involve 27 partners from 16 EU and extra-EU Member States, including patient organisations, hospitals, universities, SMEs and members of the European Federation of …

Almirall joins FACILITATE, a patient-focused Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants Read More »

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea for Nefecon for the Treatment of Primary IgA Nephropathy

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea for Nefecon for the Treatment of Primary IgA Nephropathy

— Taiwan Food and Drug Administration Grants Accelerated Approval Designation (AAD) to Nefecon — — Ministry of Food and Pharmaceutical Safety of South Korea grants ODD to Nefecon — — Nefecon is a first disease treatment for IgAN patients and has been approved in the US and EU — SHANGHAI, November 27, 2022 /PRNewswire/ — …

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea for Nefecon for the Treatment of Primary IgA Nephropathy Read More »

Access to Medicines Index 2022: AstraZeneca on patent transparency

GSK, Johnson & Johnson and AstraZeneca topped the latest Access to Medicines Index, which ranks the top 20 pharmaceutical companies for their efforts to improve access to medicines around the world. This is the eighth consecutive time that GSK has topped the list, thanks to a strategy to improve access to medicines that applies to …

Access to Medicines Index 2022: AstraZeneca on patent transparency Read More »

RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE

RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE

SINGAPORE, November 20, 2022 /PRNewswire/ — RVAC Medicines Pte. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a dedicated healthcare asset management company headquartered in Singaporeand the Agency for Science, Technology and Research (A*STAR) today announced the signing of a Master Research Collaboration Agreement to jointly investigate and develop solutions to …

RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE Read More »

UK College of Medicine's new course focuses on the healing power of food

UK College of Medicine’s new course focuses on the healing power of food

LEXINGTON, Ky. (Nov. 17, 2022) — “For some reason I really wanted fruit or salty foods when I was in treatment. Spicy, salty, salty foods — it helped keep my appetite,” recalls Yueming “Ronnie” Wu, a graduate student in chemistry at the University of Kentucky. In 2020, he was diagnosed with advanced colorectal cancer at …

UK College of Medicine’s new course focuses on the healing power of food Read More »

FDA Warns of Rising Reports of Childhood Poisonings Linked to Cough Medicines

FDA Warns of Rising Reports of Childhood Poisonings Linked to Cough Medicines

Poison control centers in the United States have seen an increase in reports of children ingesting a type of prescription cough medicine, according to a study released Tuesday by the Food and Drug Administration. From 2010 to 2018, reports of pediatric poisonings involving the drug, benzonatate, increased each year, according to the study. Benzonatate, sold …

FDA Warns of Rising Reports of Childhood Poisonings Linked to Cough Medicines Read More »